Search Results - "Valk, G D"

Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment by Berendt, A. R., Peters, E. J. G., Bakker, K., Embil, J. M., Eneroth, M., Hinchliffe, R. J., Jeffcoate, W. J., Lipsky, B. A., Senneville, E., Teh, J., Valk, G. D.

“…The International Working Group on the Diabetic Foot appointed an expert panel to provide evidence‐based guidance on the management of osteomyelitis in the…”
Get full text

The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review by Bus, S. A., Valk, G. D., van Deursen, R. W., Armstrong, D. G., Caravaggi, C., Hlaváček, P., Bakker, K., Cavanagh, P. R.

“…Background Footwear and offloading techniques are commonly used in clinical practice for the prevention and treatment of foot ulcers in diabetes, but the…”
Get full text

Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature by Sadowski, S M, Pieterman, C R C, Perrier, N D, Triponez, F, Valk, G D

“…Metastatic duodenopancreatic neuro-endocrine tumors (dpNETs) are the most important disease-related cause of death in patients with multiple endocrine…”
Get full text

Epidemiology of gastroenteropancreatic neuroendocrine tumours by Fraenkel, M., MD, Kim, M.K., MD, MSc, Faggiano, A., MD, PhD, Valk, G.D., MD, PhD

“…Abstract Gastroenteropancreatic neuroendocrine tumours are a heterogeneous group of tumours arising from diffuse endocrine cells, causing unique clinical…”
Get full text

A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes by Hinchliffe, R. J., Valk, G. D., Apelqvist, J., Armstrong, D. G., Bakker, K., Game, F. L., Hartemann-Heurtier, A., Löndahl, M., Price, P. E., van Houtum, W. H., Jeffcoate, W. J.

“…The outcome of management of diabetic foot ulcers is poor and there is uncertainty concerning optimal approaches to management. We have undertaken a systematic…”
Get full text

Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome by Pieterman, C. R. C., Schreinemakers, J. M. J., Koppeschaar, H. P. F., Vriens, M. R., Rinkes, I. H. M. Borel, Zonnenberg, B. A., Van Der Luijt, R. B., Valk, G. D.

“…Summary Objective  Effect of genetic screening on outcome in multiple endocrine neoplasia type 1 (MEN1) remains unclear. Expression of MEN1 is described using…”
Get full text

Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline by Lafeber, M, Stades, A M E, Valk, G D, Cramer, M J, Teding van Berkhout, F, Zelissen, P M J

“…BackgroundCabergoline, a dopamine agonist used to treat hyperprolactinemia, is associated with an increased risk of fibrotic adverse reactions, e.g. cardiac…”
Get full text

Unresolved issues in the management of ulcers of the foot in diabetes by Jeffcoate, W. J., Lipsky, B. A., Berendt, A. R., Cavanagh, P. R., Bus, S. A., Peters, E. J. G., Van Houtum, W. H., Valk, G. D., Bakker, K.

“…Management of diabetic foot ulcers presents a major clinical challenge. The response to treatment is often poor and the outcome disappointing, while the costs…”
Get full text

Radioactive iodine in the treatment of medullary thyroid carcinoma: a controlled multicenter study by Meijer, J A A, Bakker, L E H, Valk, G D, de Herder, W W, de Wilt, J H W, Netea-Maier, R T, Schaper, N, Fliers, E, Lips, P, Plukker, J T, Links, T P, Smit, J A

“…ObjectiveRadioactive iodine (RAI) therapy in medullary thyroid carcinoma (MTC) is applied in some centers, based on the assumption that cross-irradiation from…”
Get full text

Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature by Fraenkel, M, Kim, M, Faggiano, A, de Herder, W W, Valk, G D

“…Based on the current medical literature, the worldwide incidence of neuroendocrine tumours (NETs) seems to have increased; however, a systematic literature…”
Get full text

Carcinoid heart disease: a guide for screening and timing of surgical intervention by Hart, E. A., Meijs, T. A., Meijer, R. C. A., Dreijerink, K. M., Tesselaar, M. E., de Groot, C. A., Valk, G. D., Chamuleau, S. A. J.

“…The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical…”
Get full text

Molecular prognostic factors in small-intestinal neuroendocrine tumours by Samsom, K G, van Veenendaal, L M, Valk, G D, Vriens, M R, Tesselaar, M E T, van den Berg, J G

“…Background Small-intestinal neuroendocrine tumours (SI-NETs) represent a heterogeneous group of rare tumours. In recent years, basic research in SI-NETs has…”
Get full text

Life-threatening complications of ibogaine: three case reports by PALING, F. P, ANDREWS, L. M, VALK, G. D, BLOM, H. J

“…Ibogaine is a naturally occurring psychoactive alkaloid extracted from the roots of the Tabernanthe iboga plant, which in alternative medicine is used to treat…”
Get full text

Retroperitoneal endoscopic adrenalectomy is safe and effective by Schreinemakers, J. M. J., Kiela, G. J., Valk, G. D., Vriens, M. R., Rinkes, I. H. M. Borel

“…Background: The aim of this study was to review an experience with retroperitoneal endoscopic adrenalectomy (REA). This is the procedure of choice for adrenal…”
Get full text

Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers by van Wijk, J. P. H., Dreijerink, K. M. A., Pieterman, C. R. C., Lips, C. J. M., Zelissen, P. M. J., Valk, G. D.

“…Summary Objective  Multiple endocrine neoplasia type 1 (MEN1) is a hereditary syndrome characterized by parathyroid, gastroenteropancreatic, pituitary and…”
Get full text

Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors by Conemans, E. B., Raicu-Ionita, G. M., Pieterman, C. R. C., Dreijerink, K. M. A., Dekkers, O. M., Hermus, A. R., de Herder, W. W., Drent, M. L., van der Horst-Schrivers, A. N. A., Havekes, B., Bisschop, P. H., Offerhaus, G. J., Borel Rinkes, I. H. M., Valk, G. D., Timmers, H. Th. M., Vriens, M. R.

“…Purpose Pancreatic neuroendocrine tumors are a major manifestation of multiple endocrine neoplasia type 1 (MEN1). This tumor syndrome is caused by germline…”
Get full text

Specific guidelines on footwear and offloading by Bus, S. A., Valk, G. D., van Deursen, R. W., Armstrong, D. G., Caravaggi, C., Hlaváček, P., Bakker, K., Cavanagh, P. R.

Get full text

Specific guidelines for treatment of diabetic foot osteomyelitis by Berendt, A. R., Peters, E. J. G., Bakker, K., Embil, J. M., Eneroth, M., Hinchliffe, R. J., Jeffcoate, W. J., Lipsky, B. A., Senneville, E., Teh, J., Valk, G. D.

“…This article is based upon "The management of diabetic foot osteomyelitis - a progress report on diagnosing and a consensus on treating osteomyelitis". The…”
Get full text

Update on phenotypes of MEN1 mutation carriers by Valk, G.D.

Get full text

Patient education for preventing diabetic foot ulceration by Valk, G D, Kriegsman, D M W, Assendelft, W J J

“…Ulceration of the feet, which can result in loss of limbs and even death, is one of the major health problems for people with diabetes mellitus. To assess the…”
Get more information